NCT05246930Completed
Evaluating the Use of a Device Called Impulse Oscillometry in Participants With Vocal Cord Disorders or Asthma
The Study of Impulse Oscillometry in Inducible Laryngeal Obstruction
Source: ClinicalTrials.gov · Last updated 18 Dec 2024
Brief summary (registry, in English)
This study will determine if airway resistance to airflow and pressure, measured by Impulse Oscillometry, is impacted in subjects with vocal cord disorders and whether these measurements are different when compared to subjects with asthma.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 43 (actual)
- First submitted
- 8 Feb 2022
- Start date
- 15 Jun 2022
- Primary completion date
- 1 Jun 2024
- Lead sponsor
- University of Rochester
- Diseases
- Asthma
- NCT number
- NCT05246930
What you commit to
- Study type: Observational
- Participants enrolled: 43
- From 15 Jun 2022 to the primary completion date, 1 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Unable to provide consent or perform oscillometry test
Who the study is looking for
- Vaccinated against COVID-19 or testing negative for COVID-19 by viral PCT within 5 days before testing
- Willingness to perform breathing test
- Must be able to speak and understand English
- Documented diagnosis of asthma, documented clinical diagnosis of vocal cord dysfunction, or undergoing evaluation for vocal cord dysfunction
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mary Parkes Asthma and Allergy Center Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.